We optimize market access and value strategy in the healthcare industry. Our consulting practice combines deep market access and reimbursement expertise with industry-leading analytics to demonstrate product value to healthcare stakeholders. An extensive market access KOL network and innovative research methods inform a strategic approach to access and reimbursement. Our team of former payers and PBM executives, biopharma market access executives, pharmacists, data scientists, and business strategists work together to solve market access challenges. We help drug and device manufacturers evaluate reimbursement potential for new assets, design and translate health economics evidence, develop and validate product value platforms, respond to health policy changes, understand and support organizational customers, and formulate strategies to ensure products can break through market access barriers to get to patients. Because we believe people deserve access to the healthcare they need.